Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001585364-24-000138
Filing Date
2024-11-06
Accepted
2024-11-06 10:18:00
Documents
16
Period of Report
2024-11-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A prgo-20241106.htm   iXBRL 8-K/A 54192
2 EX-99.1 cy24q3ex991pressrelease.htm EX-99.1 998680
7 perrigoimagenew.jpg GRAPHIC 18151
  Complete submission text file 0001585364-24-000138.txt   1347582

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT prgo-20241106.xsd EX-101.SCH 4182
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT prgo-20241106_def.xml EX-101.DEF 18402
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT prgo-20241106_lab.xml EX-101.LAB 34857
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT prgo-20241106_pre.xml EX-101.PRE 19434
19 EXTRACTED XBRL INSTANCE DOCUMENT prgo-20241106_htm.xml XML 7770
Mailing Address 515 EASTERN AVENUE ALLEGAN MI 49010
Business Address THE SHARP BUILDING HOGAN PLACE DUBLIN 2 L2 D02 TY74 269-673-8451
PERRIGO Co plc (Filer) CIK: 0001585364 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-36353 | Film No.: 241429531
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)